SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-321482
Filing Date
2020-12-18
Accepted
2020-12-18 16:11:59
Documents
2
Group Members
HEALTHCAP VIII GP S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D d25322dsc13d.htm SC 13D 54565
2 EX-99.1 d25322dex991.htm EX-99.1 6569
  Complete submission text file 0001193125-20-321482.txt   62719
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91764 | Film No.: 201400717
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE D'OUCHY C/O HEALTHCAP VIII GP SA CH 1006 LAUSANNE V8 1006
Business Address 18 AVENUE D'OUCHY C/O HEALTHCAP VIII GP SA CH 1006 LAUSANNE V8 1006 41-21-614 35 00
HealthCap VIII, L.P. (Filed by) CIK: 0001783281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D